Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

222

HTML

1502

Figures (1-1)

149

Tables (1-6)

134

Sum=2007

Oct 7, 2006 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 7, 2006; 12(37): 6032-6036
Published online Oct 7, 2006. doi: 10.3748/wjg.v12.i37.6032

Full Size Figure Download Figure

Figure 1 XPD751 polymorphism and RFS under radio-5Fu/Lv treatment.

Citation: R RZ, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy. World J Gastroenterol 2006; 12(37): 6032-6036
URL: https://www.wjgnet.com/1007-9327/full/v12/i37/6032.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i37.6032